BlackRock Health Sciences Trust (BME)

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end investment fund associated with BlackRock. The vehicle focuses on U.S. listed equities, with an emphasis on companies in health sciences and related areas such as medical, dental, optical, pharmaceutical, and biotechnology products, supplies, equipment, and services. Its portfolio may also use equity derivatives, including an option-writing approach. The fund is managed by BlackRock Advisors, LLC and measures its results against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was organized on March 31, 2005 and is domiciled in the United States.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Dividend Yield Market Cap Payout Ratio
NYSE-BME
Not available
Not available
Not available
Good
December 11, 2026
December 22, 2026
7.1%
581.5 M
52.8%
Valuation • Fair Value

BlackRock Health Sciences Trust (NYSE-BME) Fair Value by Valuation Model

No usable valuation estimate is currently available for BlackRock Health Sciences Trust (NYSE-BME); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for BlackRock Health Sciences Trust (NYSE-BME). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for BlackRock Health Sciences Trust (NYSE-BME)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

7.585 M

Current operating scale indicator.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review BlackRock Health Sciences Trust (NYSE-BME) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for BlackRock Health Sciences Trust (NYSE-BME)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for BlackRock Health Sciences Trust (NYSE-BME). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for BlackRock Health Sciences Trust (NYSE-BME)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Dividend Payment Date

December 22, 2026

Ex-Dividend Date

December 11, 2026

Dividend Yield

7.1%

Current income yield reference.

Payout Ratio

52.8%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for BlackRock Health Sciences Trust (NYSE-BME), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for BlackRock Health Sciences Trust (NYSE-BME) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for BlackRock Health Sciences Trust (NYSE-BME) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for BlackRock Health Sciences Trust (NYSE-BME) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for BlackRock Health Sciences Trust (NYSE-BME) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for BlackRock Health Sciences Trust (NYSE-BME) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

BlackRock Health Sciences Trust (NYSE-BME) Stock FAQ

Data-supported answers about BlackRock Health Sciences Trust (NYSE-BME), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Good
Current financial-health read

A reliable fair value estimate is not currently available for BlackRock Health Sciences Trust (NYSE-BME). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for BlackRock Health Sciences Trust (NYSE-BME) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 7.1%, ex-dividend date is December 11, 2026, payment date is December 22, 2026.

The current market capitalization listed for BlackRock Health Sciences Trust is 581.5 M.

The ticker symbol for BlackRock Health Sciences Trust is NYSE-BME, and the stock is listed on NYSE.

BlackRock Health Sciences Trust (NYSE-BME) is listed on NYSE.